Clinical Trials Logo
  1. Home
  2. Peripheral Neuropathic Pain
  3. NCT05890053

To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia

Peripheral Neuropathic Pain Clinical Trial

Official title:
A 52-week, Open Phase III Study Evaluating the Long-term Safety and Efficacy of HSK16149 Capsules in Chinese Patients With Peripheral Neuralgia

Clinical Trial Summary

Investigate the long-term(52 weeks) safety and efficacy of HSK16149 capsules in Chinese patients with periphcral neuralgia

Clinical Trial Description

Investigate the long-term(52 weeks) safety and efficacy of HSK16149 capsules in Chinese patients with Peripheral neuropathic pain ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05890053
Study type Interventional
Source Haisco Pharmaceutical Group Co., Ltd.
Contact
Status Active, not recruiting
Phase Phase 3
Start date February 17, 2022
Completion date August 7, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT03733886 - Burst Spinal Cord Stimulation for Neuropathic Pain. N/A
Completed NCT04494815 - A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 Phase 1/Phase 2
Recruiting NCT04431778 - Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain Phase 2
Completed NCT03191136 - Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers Phase 1
Completed NCT02100046 - Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain. Phase 2
Completed NCT05416931 - ACD440 Gel in Peripheral Neuropathic Pain Phase 2
Completed NCT06234917 - Increasing Sensori-Motor Rhythm Activity by EEG-Neurofeedback to Reduce the Impact of Pain on Daily Functioning N/A
Completed NCT03009500 - Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain Phase 3
Completed NCT01524796 - NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark
Completed NCT02985216 - Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain Phase 3
Recruiting NCT04171453 - Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets
Completed NCT01737294 - Observation of the Use of QUTENZA™ in Standard Clinical Practice N/A
Completed NCT05219812 - A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain Phase 2
Terminated NCT01293851 - Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage
Completed NCT02209896 - BlueWind Reprieve System for the Treatment of PNP N/A
Completed NCT01240148 - Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers Phase 1
Recruiting NCT05817591 - Response Profiles to High-concentration Capsaicin Desensitization in Patients With Peripheral Neuropathic Pain With or Without Allodynia: a Regional Multicenter Prospective Cohort